Position in VRTX
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$4,470
New position
Shares Held
9
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,641
of 1,705 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Mosley Wealth Management holds $36,238 across 6 Biotechnology names. VRTX ranks #2 (12.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
47 | $29,306 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
9 | $4,470 | |
| 3 | PBYI |
Puma Biotechnology, Inc.
|
148 | $1,200 | |
| 4 | EXEL |
Exelixis, Inc.
|
20 | $1,088 | |
| 5 | PCVX |
Vaxcyte, Inc.
|
3 | $174 | |
| 6 | RVPH |
Reviva Pharmaceuticals Holdings, Inc.
|
1 | $0 |
All Filings in VRTX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,470 | 9 | Shares | Sole | 2026-07-23 | |
| No filing history on record for this holder in this stock. | ||||||